Where Does eFFECTOR Therapeutics Inc (EFTR) Stock Fall in the Biotechnology Field After It Has Risen 34.65% This Week?

A rating of 93 puts eFFECTOR Therapeutics Inc (EFTR) near the top of the Biotechnology industry according to InvestorsObserver. eFFECTOR Therapeutics Inc's score of 93 means it scores higher than 93% of stocks in the industry. eFFECTOR Therapeutics Inc also received an overall rating of 81, putting it above 81% of all stocks. Biotechnology is ranked 19 out of the 148 industries.

EFTR has an Overall Score of 81. Find out what this means to you and get the rest of the rankings on EFTR!

See Full EFTR Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 81 means the stock is more attractive than 81 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With eFFECTOR Therapeutics Inc Stock Today?

eFFECTOR Therapeutics Inc (EFTR) stock is down -1.45% while the S&P 500 is up 0.25% as of 10:24 AM on Monday, Jun 12. EFTR is down -$0.02 from the previous closing price of $1.38 on volume of 432,088 shares. Over the past year the S&P 500 has risen 14.93% while EFTR is down -9.33%. EFTR lost -$0.86 per share the over the last 12 months. Click Here to get the full Stock Report for eFFECTOR Therapeutics Inc stock.